Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alina Desiree Sandø

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Acta Oncologica (Stockholm, Sweden)|October 30, 2023
Does the ypTNM-stage adequately predict long-term survival rates in gastric cancer patients receiving neoadjuvant chemotherapy followed by radical resection?Alina Desiree Sandø, Jon Erik Grønbech, Erling Audun Bringeland
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|December 9, 2010
[Routines for first prescription of oral contraceptives]Alina Desiree Sandø, Siv Gyda Aanes, Lars Slørdal, et al.
World Journal of Surgical Oncology|July 14, 2021
The value of restaging CT following neoadjuvant chemotherapy for resectable gastric cancer. A population-based studyAlina Desiree Sandø, Reidun Fougner, Jon Erik Grønbech, et al.
Cancers|May 16, 2023
Response Evaluation after Neoadjuvant Chemotherapy for Resectable Gastric CancerAlina Desiree Sandø, Reidun Fougner, Elin Synnøve Røyset, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Acta Oncologica (Stockholm, Sweden)|October 30, 2023
Does the ypTNM-stage adequately predict long-term survival rates in gastric cancer patients receiving neoadjuvant chemotherapy followed by radical resection?Alina Desiree Sandø, Jon Erik Grønbech, Erling Audun Bringeland
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|December 9, 2010
[Routines for first prescription of oral contraceptives]Alina Desiree Sandø, Siv Gyda Aanes, Lars Slørdal, et al.
World Journal of Surgical Oncology|July 14, 2021
The value of restaging CT following neoadjuvant chemotherapy for resectable gastric cancer. A population-based studyAlina Desiree Sandø, Reidun Fougner, Jon Erik Grønbech, et al.
Cancers|May 16, 2023
Response Evaluation after Neoadjuvant Chemotherapy for Resectable Gastric CancerAlina Desiree Sandø, Reidun Fougner, Elin Synnøve Røyset, et al.
Pageof 1